These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 33543022)
1. miR-200b restrains EMT and aggressiveness and regulates matrix composition depending on ER status and signaling in mammary cancer. Piperigkou Z; Franchi M; Riethmüller C; Götte M; Karamanos NK Matrix Biol Plus; 2020 May; 6-7():100024. PubMed ID: 33543022 [TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor beta as epigenetic mediator of miR-10b and miR-145 in mammary cancer. Piperigkou Z; Franchi M; Götte M; Karamanos NK Matrix Biol; 2017 Dec; 64():94-111. PubMed ID: 28797712 [TBL] [Abstract][Full Text] [Related]
3. Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer. Rhodes LV; Martin EC; Segar HC; Miller DF; Buechlein A; Rusch DB; Nephew KP; Burow ME; Collins-Burow BM Oncotarget; 2015 Jun; 6(18):16638-52. PubMed ID: 26062653 [TBL] [Abstract][Full Text] [Related]
4. miR-200b regulates epithelial-mesenchymal transition of chemo-resistant breast cancer cells by targeting FN1. Yang X; Hu Q; Hu LX; Lin XR; Liu JQ; Lin X; Dinglin XX; Zeng JY; Hu H; Luo ML; Yao HR Discov Med; 2017 Sep; 24(131):75-85. PubMed ID: 28972876 [TBL] [Abstract][Full Text] [Related]
5. Mapping the regulatory sequences controlling 93 breast cancer-associated miRNA genes leads to the identification of two functional promoters of the Hsa-mir-200b cluster, methylation of which is associated with metastasis or hormone receptor status in advanced breast cancer. Wee EJ; Peters K; Nair SS; Hulf T; Stein S; Wagner S; Bailey P; Lee SY; Qu WJ; Brewster B; French JD; Dobrovic A; Francis GD; Clark SJ; Brown MA Oncogene; 2012 Sep; 31(38):4182-95. PubMed ID: 22231446 [TBL] [Abstract][Full Text] [Related]
6. MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1. Sun L; Yao Y; Liu B; Lin Z; Lin L; Yang M; Zhang W; Chen W; Pan C; Liu Q; Song E; Li J Oncogene; 2012 Jan; 31(4):432-45. PubMed ID: 21725369 [TBL] [Abstract][Full Text] [Related]
7. Autocrine/Paracrine Human Growth Hormone-stimulated MicroRNA 96-182-183 Cluster Promotes Epithelial-Mesenchymal Transition and Invasion in Breast Cancer. Zhang W; Qian P; Zhang X; Zhang M; Wang H; Wu M; Kong X; Tan S; Ding K; Perry JK; Wu Z; Cao Y; Lobie PE; Zhu T J Biol Chem; 2015 May; 290(22):13812-29. PubMed ID: 25873390 [TBL] [Abstract][Full Text] [Related]
8. The Role of miR-200b-3p in Modulating TGF-β1-induced Injury in Human Bronchial Epithelial Cells. Ladak SS; Roebuck E; Powell J; Fisher AJ; Ward C; Ali S Transplantation; 2019 Nov; 103(11):2275-2286. PubMed ID: 31283671 [TBL] [Abstract][Full Text] [Related]
9. Association of microRNA-93, 190, 200b and receptor status in core biopsies from stage III breast cancer patients. Kolacinska A; Morawiec J; Pawlowska Z; Szemraj J; Szymanska B; Malachowska B; Morawiec Z; Morawiec-Sztandera A; Pakula L; Kubiak R; Zawlik I DNA Cell Biol; 2014 Sep; 33(9):624-9. PubMed ID: 24865188 [TBL] [Abstract][Full Text] [Related]
10. Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-β-induced epithelial-mesenchymal transition and metastasis by controlling TIF1γ in non-small cell lung cancer. Wang L; Tong X; Zhou Z; Wang S; Lei Z; Zhang T; Liu Z; Zeng Y; Li C; Zhao J; Su Z; Zhang C; Liu X; Xu G; Zhang HT Mol Cancer; 2018 Sep; 17(1):140. PubMed ID: 30261900 [TBL] [Abstract][Full Text] [Related]
11. Good or not good: Role of miR-18a in cancer biology. Kolenda T; Guglas K; Kopczyńska M; Sobocińska J; Teresiak A; Bliźniak R; Lamperska K Rep Pract Oncol Radiother; 2020; 25(5):808-819. PubMed ID: 32884453 [TBL] [Abstract][Full Text] [Related]
12. Reduced expression of miR-200 family members contributes to antiestrogen resistance in LY2 human breast cancer cells. Manavalan TT; Teng Y; Litchfield LM; Muluhngwi P; Al-Rayyan N; Klinge CM PLoS One; 2013; 8(4):e62334. PubMed ID: 23626803 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-regulated gene networks during mammary cell differentiation are associated with breast cancer. Aydoğdu E; Katchy A; Tsouko E; Lin CY; Haldosén LA; Helguero L; Williams C Carcinogenesis; 2012 Aug; 33(8):1502-11. PubMed ID: 22562546 [TBL] [Abstract][Full Text] [Related]
14. HIF-1α/Ascl2/miR-200b regulatory feedback circuit modulated the epithelial-mesenchymal transition (EMT) in colorectal cancer cells. Shang Y; Chen H; Ye J; Wei X; Liu S; Wang R Exp Cell Res; 2017 Nov; 360(2):243-256. PubMed ID: 28899657 [TBL] [Abstract][Full Text] [Related]
15. Estrogen receptor alpha mediates epithelial to mesenchymal transition, expression of specific matrix effectors and functional properties of breast cancer cells. Bouris P; Skandalis SS; Piperigkou Z; Afratis N; Karamanou K; Aletras AJ; Moustakas A; Theocharis AD; Karamanos NK Matrix Biol; 2015 Apr; 43():42-60. PubMed ID: 25728938 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways. Keklikoglou I; Koerner C; Schmidt C; Zhang JD; Heckmann D; Shavinskaya A; Allgayer H; Gückel B; Fehm T; Schneeweiss A; Sahin O; Wiemann S; Tschulena U Oncogene; 2012 Sep; 31(37):4150-63. PubMed ID: 22158050 [TBL] [Abstract][Full Text] [Related]
17. Role of p38γ MAPK in regulation of EMT and cancer stem cells. Xu M; Wang S; Wang Y; Wu H; Frank JA; Zhang Z; Luo J Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3605-3617. PubMed ID: 30251680 [TBL] [Abstract][Full Text] [Related]
18. Progesterone receptor A promotes invasiveness and metastasis of luminal breast cancer by suppressing regulation of critical microRNAs by estrogen. McFall T; McKnight B; Rosati R; Kim S; Huang Y; Viola-Villegas N; Ratnam M J Biol Chem; 2018 Jan; 293(4):1163-1177. PubMed ID: 29162724 [TBL] [Abstract][Full Text] [Related]
19. miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy. Adam L; Zhong M; Choi W; Qi W; Nicoloso M; Arora A; Calin G; Wang H; Siefker-Radtke A; McConkey D; Bar-Eli M; Dinney C Clin Cancer Res; 2009 Aug; 15(16):5060-72. PubMed ID: 19671845 [TBL] [Abstract][Full Text] [Related]
20. EGFR is a pivotal player of the E2/ERβ - mediated functional properties, aggressiveness, and stemness in triple-negative breast cancer cells. Kyriakopoulou K; Kefali E; Piperigkou Z; Riethmüller C; Greve B; Franchi M; Götte M; Karamanos NK FEBS J; 2022 Mar; 289(6):1552-1574. PubMed ID: 34665934 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]